Hemophilia A Clinical Trials in Seattle, Washington

4 studies are recruiting for hemophilia a in Seattle, Washington right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

   The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of NXT007 prophylaxis compared with emicizumab prophylaxis in people age 12 years and older with severe or moderate congenital hemophilia A without factor VIII (FVIII) inhibitors or with hemophilia…

   Stage

   Phase 3

   Ages

   12 and older

   Site

   Washington Center for Bleeding Disorders, Seattle, Washington

   Locations

   42 in total

   Run by

   Hoffmann-La Roche

   See if you can join NCT07416604 on ClinicalTrials.gov

2. Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

   Study B7841007 is an open-label extension study to assess the long-term safety, tolerability, and efficacy of prophylaxis treatment with marstacimab in participants who did not require "Early Termination" from the Phase 3 Study B7841005 and from the Phase 3 Study B7841008. Study B7841005: approxima…

   Stage

   Phase 3

   Ages

   1 to 74

   Site

   Washington Institute for Coagulation d/b/a WACBD, Seattle, Washington

   Locations

   75 in total

   Run by

   Pfizer

   See if you can join NCT05145127 on ClinicalTrials.gov

3. Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

   A study to learn about the long-term safety and efficacy of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B respectively, who have received treatment through prior participation in a Pfizer-sponsored clinical trial. Data collection and participa…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Washington Institute for Coagulation, Seattle, Washington

   Locations

   23 in total

   Run by

   Pfizer

   See if you can join NCT05568719 on ClinicalTrials.gov

4. Hemophilia A Research Program

   This study longitudinally observes the intergenerational (mother-child) continuum in hemophilia A from pregnancy through early childhood. Because the study follows mother-child pairs, the study includes both a maternal cohort and a pediatric cohort. Each cohort has a primary goal: for the mother wi…

   Stage

   Not phased

   Ages

   Any age

   Site

   University of Washington, Seattle, Washington

   Run by

   University of Washington

   See if you can join NCT07414511 on ClinicalTrials.gov